Hebei Weimiao Biology Co., LTD 1
Location
  • Home
  • cas 870888-46-3 ac-262536

Dec . 05, 2024 19:48 Back to list

cas 870888-46-3 ac-262536



Exploring AC-262536 A Novel Chemical Compound in Research


AC-262536, known by its CAS number 87088-46-3, represents an intriguing area of research in the field of biochemistry and pharmacology. This compound, a selective androgen receptor modulator (SARM), has garnered attention due to its potential applications in muscle wasting disorders and performance enhancement in athletic contexts. Given the growing interest in SARMs, it’s essential to understand their mechanisms, potential benefits, and implications for future therapeutic applications.


What Are SARMs?


Selective androgen receptor modulators (SARMs) are a class of compounds that bind to androgen receptors in the body. Unlike traditional anabolic steroids, which affect a range of tissues and often lead to undesirable side effects, SARMs are designed to selectively target specific tissues. This selectivity means that they can promote muscle growth and fat loss with fewer side effects. AC-262536 is one of the most well-studied SARMs, showcasing a strong affinity for androgen receptors while minimizing risks associated with long-term use.


Mechanism of Action


Exploring AC-262536 A Novel Chemical Compound in Research

Potential Therapeutic Applications


cas 870888-46-3 ac-262536

cas 870888-46-3 ac-262536

The implications of AC-262536 extend beyond just athletic performance. With an aging population and the rise of chronic illnesses, there is a critical need for effective treatments to address muscle loss. Conditions caused by aging, immobilization, or chronic diseases can lead to significant morbidity and adversely affect quality of life. AC-262536's potential to stimulate muscle growth offers a promising avenue for developing therapies aimed at preserving muscle mass and improving functional outcomes in these patients.


In addition, the selective nature of SARMs like AC-262536 potentially allows for a better safety profile compared to traditional anabolic steroids. This selectivity may lead to fewer side effects, such as hormonal imbalances and liver toxicity that are commonly associated with anabolic steroid use. Consequently, research into AC-262536 could provide critical insights into safer alternatives for both therapeutic and performance enhancement uses.


Current Research and Outlook


Studies investigating AC-262536 have shown promising results, particularly regarding its anabolic effects on muscle tissue. However, comprehensive clinical trials are necessary to determine the long-term effects and safety profile of the compound in humans. The scientific community is increasingly focused on understanding SARMs, exploring both their benefits and potential risks. Regulators and health organizations are also paying close attention to the use of SARMs, particularly in sports, where athletes might seek to exploit these compounds for performance enhancement.


Conclusion


AC-262536, as a selective androgen receptor modulator, represents a fascinating subject of study within the realm of pharmacology and biochemistry. With its potential applications in both therapeutic settings and athletics, this compound is at the forefront of research aimed at improving health outcomes. However, as research progresses, it is crucial to balance the promising benefits with a thorough understanding of any associated risks. The future of AC-262536 and similar compounds will undoubtedly rely on rigorous scientific investigation to elucidate their full range of effects and safe applications.


Share
Next：

Latest news

If you are interested in our products, you can choose to leave your information here, and we will be in touch with you shortly.


Hit enter to search or ESC to close
sl_SISlovenian
en_USEnglish afAfrikaans sqAlbanian amAmharic arArabic hyArmenian azAzerbaijani euBasque belBelarusian bn_BDBengali bs_BABosnian bg_BGBulgarian caCatalan cebCebuano zh_CNChina zh_TWChina (Taiwan) coCorsican hrCroatian cs_CZCzech da_DKDanish nl_NLDutch eoEsperanto etEstonian fiFinnish fr_FRFrench fyFrisian gl_ESGalician ka_GEGeorgian de_DEGerman elGreek guGujarati htHaitian Creole haHausa hawHawaiian he_ILHebrew hi_INHindi hmnMiao hu_HUHungarian is_ISIcelandic igIgbo id_IDIndonesian gaIrish it_ITItalian jaJapanese jvJavanese knKannada kkKazakh kmKhmer rwRwandese ko_KRKorean ckbKurdish kyKyrgyz loLao laLatin lvLatvian lt_LTLithuanian lbLuxembourgish mk_MKMacedonian mgMalgashi ms_MYMalay ml_INMalayalam mtMaltese miMaori mrMarathi mnMongolian my_MMMyanmar ne_NPNepali nb_NONorwegian nyNorwegian orOccitan psPashto fa_IRPersian pl_PLPolish pt_PTPortuguese pa_INPunjabi ro_RORomanian ru_RURussian smSamoan gdScottish Gaelic sr_RSSerbian stSesotho snShona sdSindhi si_LKSinhala sk_SKSlovak soSomali es_ESSpanish suSundanese swSwahili sv_SESwedish tlTagalog tgTajik ta_INTamil tt_RUTatar teTelugu thThai tr_TRTurkish tkTurkmen ukUkrainian urUrdu ug_CNUighur uz_UZUzbek viVietnamese cyWelsh xhBantu yiYiddish yoYoruba zuZulu sl_SISlovenian